Pharmafile Logo
Pharmafocus logo
Advanced Search

Orphan

Showing 14 posts of 14 posts found.

astrazeneca image

AstraZeneca lung drug shows promise

April 20, 2015
Sales and Marketing AZ, AZD9291, AstraZeneca, European Lung Cancer Congress, NSCLC, Orphan

AstraZeneca’s non-small cell lung cancer offering AZD9291 has been shown to delay disease progression by over a year. Data presented …

News
Roche image

Roche buys French biotech for €470 million

January 19, 2015
Sales and Marketing Foundation, Genentech, Orphan, Roche, TRO19622, olesoxime, sma, trophos

Roche is buying France-based biotech Trophos in a deal worth up to €470 million in order to gain access to …

News
Esbriet image

Shortlist announced for best new pharma product

June 24, 2014
Research and Development, Sales and Marketing Esbriet, InterMune, Lemtrada, Orphan, dificlir, innovative, pif, prix galion, selincro

Treatments for idiopathic pulmonary fibrosis, hepatic encephalopathy and meningococcal infection are among 14 new medicines shortlisted for the UK Prix …

News
biogen_austria_238

Biogen gets CHMP thumbs up

May 27, 2014
Sales and Marketing Biogen, CHMP, Gazyvaro (obinutuzumab), Nuwiq, Octapharma, Orphan, Roche, chronic lymphocytic leukaemia, plegridy

Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …

News

Roche ‘considers’ Alexion bid

July 16, 2013
Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris

Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …

News

Orphan drug for Astellas

May 29, 2013
Sales and Marketing Astellas, Isavuconazole, Orphan

The FDA has granted orphan designation to one of Astellas’ Phase III drugs designed to treat potentially life-threatening fungal infections …

News
EMA image

EU orphan designations rise

February 19, 2013
Research and Development, Sales and Marketing COMP, EMA, Orphan, hta

The number of orphan drug designations in the EU is set to rise to record levels this year, according to …

News

Pfizer forms rare diseases unit

June 15, 2010
Research and Development Orphan, Pfizer

Pfizer is seeking to boost its coverage of research into orphan conditions with the creation of a new unit focused …

News

Orphan and rare disease marketers: are you armed for success?

March 8, 2010
Business Services, Sales and Marketing Orphan

Many marketers are currently unfamiliar with the specific approaches required in orphan and rare disease (ORD) brands, but will need …

Feature

Single orphan document will simplify process for industry

March 1, 2010
Research and Development EMA, FDA, Orphan

The FDA and European Medicines Agency are to simplify the regulatory process for orphan medicines by agreeing to accept a …

News

GSK looks to rare diseases research

February 5, 2010
Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …

News

Marketing in rare diseases – getting closer to your customers

January 20, 2010
Sales and Marketing Orphan, marketing, marketing ideas, niche

The 21st century healthcare industry is reorientating its strategic focus on the increasingly successful areas of orphan and rare diseases. …

Feature

Biopharma company contributes to GSK’s ‘patent pool’

July 10, 2009
Research and Development Orphan

Biopharma company Alnylam Pharmaceuticals is to put some of its intellectual property at the disposal of researchers into neglected tropical …

News

Merck takes aim at neglected tropical diseases

June 25, 2009
Research and Development, Sales and Marketing Africa, Merck, Orphan

Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024